Aluminum modulates effects of βamyloid1-42 on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease

Rejuvenation Research

Volumn 11, Issue 5, 2008, Pages 861-871

  Drago, Denise ^a   Cavaliere, Alessandra ^a   Mascetra, Nicola ^b   Ciavardelli, Domenico ^b   Di Ilio, Carmine ^b   Zatta, Paolo ^a   Sensi, Stefano L ^b,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM HOMEOSTASIS; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE MODEL; EMBRYO; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

ALUMINUM; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; MALE; MEMBRANE FLUIDITY; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MULTIPROTEIN COMPLEXES; N-METHYLASPARTATE; NEURONS; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 54249163572     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0761     Document Type: Article

References (72)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-356.
2. Dahlgren KN, Manelli AM, Stine WB, Jr., Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002;277:32046-32053.
3. Tanzi RE. The synaptic Abeta hypothesis of Alzheimer's disease. Nat Neurosci 2005;8:977-979.
4. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 2000;39:10831-10839.
5. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 2000;156:15-20.
6. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer's disease. A link between Abeta and tau pathology. J Biol Chem 2006;281:1599-1604.
7. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 2007;8:499-509.
8. Lovell MA, Ehmann WD, Markesbery WR. Laser microprobe analysis of brain aluminum in Alzheimer's disease. Ann Neurol 1993;33:36-42.
9. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.
10. Beauchemin D, Kisilevsky R. A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Anal Chem 1998;70:1026-1029.
11. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 2003;42:2768-2773.
12. Miu AC, Benga O. Aluminum and Alzheimer's disease: a new look. J Alzheimers Dis 2006;10:179-201.
13. Zatta P, Lucchini R, van Rensburg SJ, Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 2003;62:15-28.
14. Zatta, P. Metal Ions and Neurodegeneration Disorders. World Scientific, Singapore, London, 2003.
15. Liu G, Huang W, Moir RD, Vanderburg CR, Lai B, Peng Z, Tanzi RE, Rogers JT, Huang X. Metal exposure and Alzheimer's pathogenesis. J Struct Biol 2006;155:45-51.
16. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX. Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 2005;86:147-159.
17. Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P. Aluminum-triggered structural modifications and aggregation of beta-amyloids. Cell Mol Life Sci 2005;62:1724-1733.
18. Drago D, Folin M, Baiguera S, Tognon G, Ricchelli F, Zatta P. Comparative effects of Abeta(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis 2007;11:33-44.
19. Drago D, Bettella M, Bolognin S, Cendron L, Scancar J, Milacic R, Ricchelli F, Casini A, Messori L, Tognon G, Zatta P. Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease. Int J Biochem Cell Biol 2008;40:731-746.
20. Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, Ravid R, Shankar SK, Stein R, Shanmugavelu P, Jagannatha Rao KS. Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol Life Sci 2005;62:143-158.
21. Kawahara M, Kato M, Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull 2001;55:211-217.
22. Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 2005;8:171-182; discussion 209-115.
23. Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 2002;16:1138-1140.
24. House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 2004;6:291-301.
25. Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem 2007;101:1172-1184.
26. LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002;3:862-872.
27. Mattson MP. Calcium and neurodegeneration. Aging Cell 2007;6:337-350.
28. Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007;6:307-317.
29. Khachaturian ZS. Calcium hypothesis of Alzheimer's disease and brain aging. Ann N Y Acad Sci 1994;747:1-11.
30. Pierrot N, Ghisdal P, Caumont AS, Octave JN. Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem 2004;88:1140-1150.
31. Mattson MP, Chan SL. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci 2001;17:205-224.
32. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di Lisa F, Forte MA. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006;273:2077-2099.
33. Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, Martinez-Murillo R, Martinez A, Rodrigo J. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol Histopathol 2004;19:823-844.
34. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004;304:448-452.
35. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001;21:3017-3023.
36. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409-421.
37. Sensi SL, Canzoniero LM, Yu SP, Ying HS, Koh JY, Kerchner GA, Choi DW. Measurement of intracellular free zinc in living cortical neurons: routes of entry. J Neurosci 1997;17:9554-9564.
38. Nicholls DG. Calcium transport and porton electrochemical potential gradient in mitochondria from guinea-pig cerebral cortex and rat heart. Biochem J 1978;170:511-522.
39. Szollòsi, J. Fluidity/Viscosity of Biological Membranes. In: Damjanovich S, Szollòsi J, Tròn L, Edidin M, eds: Mobility and Proximity in Biological Membranes. CRC Press, Boca Raton, 1994, pp. 137-208.
40. Van der Meer, BW. Fluorescence studies on biological membranes. In: Hilderson HJ, Harris JR, eds: Subcellular Biochemistry, vol. 13. Plenum Press, New York, 1988 , pp. 1-53.
41. Petronilli V, Cola C, Massari S, Colonna R, Bernardi P. Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J Biol Chem 1993;268:21939-21945.
42. Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, Bush AI. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer's beta-amyloid pathology. J Inorg Biochem 2006;100:952-962.
43. Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, Letellier T, Dachary-Prigent J, Solaini GC, Rossignol R. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr 2005;37:207-225.
44. Muller WE, Kirsch C, Eckert GP. Membrane-disordering effects of beta-amyloid peptides. Biochem Soc Trans 2001;29:617-623.
45. Gomez M, Sánchez DJ, Llobet JM, Corbella J, Domingo JL. Concentrations of some essential elements in the brain of aluminium-exposed rats in relation to the age of exposure, Arch Gerontol Geriatr 1997;24:287-294.
46. Kraizer RR, Correa MC, Gris LR, da Rosa CS, Bohrer D, Morsch VM, Schetinger MR. Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes. Neurochem Res 2008; Epub ahead of print; DOI: 10.1007/s11064-008-9725-6.
47. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 2005;280:17294-17300.
48. Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 2000;28:285-296.
49. Toescu EC, Verkhratsky A. Assessment of mitochondrial polarization status in living cells based on analysis of the spatial heterogeneity of rhodamine 123 fluorescence staining. Pflugers Arch 2000;440:941-947.
50. Crouch PJ, Cimdins K, Duce JA, Bush AI, Trounce IA. Mitochondria in Aging and Alzheimer's disease. Rejuvenation Res 2007;10:349-357.
51. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. Betaamyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002;80:91-100.
52. Moreira PI, Santos MS, Moreno AM, Seica R, Oliveira CR. Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure. Diabetes 2003;52:1449-1456.
53. Canevari L, Abramov AY, Duchen MR. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res 2004;29:637-650.
54. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 2005;19:2040-2041.
55. Burnatowska-Hledin M, Ebner KV, Mayor GH. In vivo and in vitro effects of aluminum treatment on rat liver mitochondrial function. Biol Trace Element Res 1986;10:235-242.
56. Andreyev A, Fiskum G. Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain vs. liver. Cell Death Differ 1999;6:825-832.
57. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 2002;69:257-267.
58. Panov AV, Andreeva L, Greehamyre JT. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. Arch Biochem Biophys 2004;424:44-52.
59. Verstraeten SV, Erleman AG, Zago MP, Oteiza PI. Aluminum affects membrane physical properties in human neuroblastoma (IMR-32) cells both before and after differentiation. Arch Biochem Biophys 2002;399:167-173.
60. Zhang NY, Kitagawa K, Hattori N, Nakayama Y, Xiong ZM, Liu B, Inagaki C. Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid β protein-induced degeneration of hippocampal neurons in V337M human tau-expressing mice. Life Sci 2007;80:1971-1976.
61. Fu W and Jhamandas JH. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J Neurophysiol 2003;90:3130-3136.
62. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ, Di Virgilio F, Pozzan T. Calcium and apoptosis: facts and hypotheses. Oncogene 2003;22:8619-8627.
63. Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 2001;26:112-117.
64. Moreira PI, Santos MS, Moreno A, Oliveira C. Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 2001;21:789-800.
65. Shevtzova EF, Kireeva EG, Bachurin SO. Effect of beta-amyloid peptide fragment 25-35 on nonselective permeability of mitochondria. Bull Exp Biol Med 2001;132:1173-1176.
66. Zatta P. Aluminum and Alzheimer's disease: a Vexata Questio between uncertain data and a lot of imagination. J Alzheimers Dis 2006;10:33-37.
67. Walton JR. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 2006;27:385-394.
68. Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis 2006;10:223-253.
69. Klatzo I, Wisniewski H, Streicher E. Experimental Production of Neurofibrillary Degeneration. I. Light Microscopic Observations. J Neuropathol Exp Neurol 1965;24:187-199.
70. Perl DP, Brody AR. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980;208:297-299.
71. Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1986;1:354-357.
72. Banks WA, Niehoff ML, Drago D, Zatta P. Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier. Brain Res 2006;1116:215-221.